Penn Medicine Co-Investment Program Investor

Drug development generally moves at a snail’s pace, with therapies taking an average of 10 to 15 years and costing upwards of $1 billion to trudge from concept to market. For every drug that “makes it,” more than 5,000 fail. Anyone working in academic medical research is aware of the long and winding pathway an experimental therapy must ...

Headquarters: Philadelphia, Pennsylvania, United States
Number Of Exists: 1
Investor Type: Venture Capital
Investment Stage: Convertible Note, Early Stage Venture, Late Stage Venture, Seed, Venture